Recently, we have found out that some people in China are using the name of BIT to set-up false conference sites, in order for our participants to identify BIT's conferences, please click here for our forthcoming confereces! BIT will not take any responsibilities for conferences which are not listed.

Hosting Organization
Operating Organization

Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision

BIT Lifesciences, Inc.
Supporting Organization
International Marketing Partner

Participants List

National Yang-Ming University, Taiwan

Abyad Medical Center and Middle-East Longevity Institute, Lebanon

Akershus University Hospital, Norway

Aligarh M University, India

American University of Beirut, USA

Antwerp University Hospital, Belgium

Applied Proteomics and Molecular Medicine, USA

Aristotelian University of Thessaloniki, Greece

Banaras Hindu University, India

Barrow Neurological Institute, USA

Baylor College of Medicine, USA

Ben-Gurion University of the Negev, Israel

Boston University School of Medicine, USA

Cancer Research Technology, UK

CHDI Foundation, California

Chinese Academy of Sciences, China

CRG-Centre de Regulaci Genmica, Spain

CSIRO Molecular and Health Technologies, Australia

Duke University, USA

Emory University, USA

exas Southern University, USA

Florida A&M University, USA

Global Pathology Support, The Netherlands

Gujarat AIDS Awareness and Prevention Unit, India

Haematopoietic Stem Cell Laboratory, UK

Harvard Medical School, USA

Hospital S Hospital S Joao, Portugal

Human BioMolecular Re-. search Institute, USA

Indiana University School of Medicine, USA

Indiana University School of Medicine, USA

Innsbruck Medical University, Austria

Institute of Experimental Pharmacology, Slovak

Instituto De Biologia Experimentale Tecnologica, Portugal

Karolinska Institutet, Sweden

Keystone College Academia, USA

McGill University, Canada

Mercer University, USA

National Center for Toxicological Research, USA

National Institutes of Health, USA

Netherlands Cancer Institute, The Netherlands
New York Medical College, USA

Osaka University, Japan

Paul-Ehrlich-Institute, Germany

Penn State College of Medicine, USA

Pennsylvania State University College of Medicine, USA

Pharmacology Temple University, USA

Scientific Advisory Board Tolerx, USA 

Shanghai Unviversity of Traditional Chinese Medicine, China

Solid Tumor Working Party, Italy

Stanford University, USA

Structural Genomics Consortium Karolinska Institutet, Sweden

Tabriz University of Medical Sciences, Iran

Technion - Israel Institute of Technology Rappaport Institute, Israel

The Babraham Institute, UK

The Hebrew University, Israel

The Institute of Cancer Research, UK

The University of Queensland, Australia

The University of Sydney, Australia

The University of Texas, USA

UC College of Medicine, USA

Universidade Federal Fluminense, Brazil

University Clinic Bonn, Germany

University of Basel, Switzerland

University of British Columbia, Canada

University of California, USA

University of California-San Francisco, USA

University of Camerino, Italy

University of Cape Town, USA

University of Colorado Health Sciences Center, USA

University of Crete, Greece

University of Geneva, Switzerland

University of Heidelberg, Germany

University of Hong Kong, China

University of Maryland School of Pharmacy, USA

University of Maryland, USA

University of Massachusetts Medical School, USA

University of Miami School of Medicine, USA

University of Miami, USA

University of Miami, USA

University of Oklahoma Health Sciences Center, USA

University of Siena, Italy

University of Southern Denmark, Denmark

University of Texas at Dallas, USA

University of Texas Health Science Center, USA

University of Texas Medical, USA

University of the Sciences in Philadelphia, USA

University of Utah School of Medicine, USA

University of Western Australia, Australia

Utah State University, USA

Virginia Commonwealth University, USA

University of Gothenburg, Sweden

Participants List

3 P Biopharmaceuticals, USA

Abbott Laboratories, USA

Adolor Corporation, USA

Affimed Therapeutics AG, Germany

AILERON Therapeutics, USA

Algorithme Pharma Inc., Canada

Allon Therapeutics Inc., USA

Alpha Cancer Technologies Inc., USA

Alpha-2 Pharmaceutica AB, Israel

Amgen, Inc., USA

Arena Pharmaceuticals, USA

Astellas Pharma Inc, Japan

Astellas Pharmaceutical Inc., Japan

AstraZeneca Pharmaceuticals, USA

AstraZeneca R&D Molndal, Sweden

Astrazeneca R&D Sodertolje, Sweden

AstraZeneca, UK

AstraZeneca, USA

AuxoCell Laboratories, Inc., USA

Avexa Ltd, Australia

Bayer HealthCare, USA

Bayer Schering Pharma AG, Germany

BellBrook Labs, LLC, USA

Biological Mimetics, Inc., USA

BioPerspectives, USA

Biota Holdings Limited, USA

Boehringer Ingelheim Pharmaceuticals, Inc., USA

Bristol-Myers Squibbs, USA

Centocor/Johnson & Johnson, USA

Chemistry Forma Therapeutics, Inc., Singapore

Coley Pharmaceutical GmbH, Germany

Cordex Pharma, Inc., USA

Cornerstone Pharmaceuticals, USA

Covidien, USA

Daiichi Sankyo Pharma Development, Japan

deCODE Chemistry, USA

DxS Ltd, USA

Eisai Co., Ltd., Japan

Elan Pharmaceuticals, USA

Europe GlaxoSmithKline R&D, UK

Genentech, USA

Genetix Ltd, UK

genscript, USA

Genzyme Pharmaceuticals, USA

Gilead Sciences Benzothiadiazine Hepatitis C NS5B, USA

Hoffmann-La Roche, Switzerland

IDDC Corporation, USA

Idera Pharmaceuticals, USA

Jesus College, England

Johnson & Johnson Pharmaceutical, USA

Johnson & Johnson Research Pty Limited, Australia

Laboratory Cellular Technology Ltd., USA

Lundbeck Research, USA

Mallinckrodt, Inc., USA

MDS Pharma Services, USA

Medimmune, UK

Merck & Co. Inc, USA

Merck & Co., Italy

Merck and Co., Inc., China

Merck KGaA, Germany

Merck Research Laboratories, USA

Nerviano Medical Sciences, Italy

Novartis Institutes for Biomedical Research, USA

Novartis Institutes, Switzerland

Novartis Pharmaceuticals Corporation, USA

Novartis, China

Ocimum Biosolutions, India

Ondokuz Mayis University, Turkey

OphthalmoPharma, Switzerland
Pfizer, USA

Pharmanet Development Group, Inc., USA

PharmaNet, Inc., USA

Ranbaxy Laboratories Limited, India

Reaction Biology Corporation, USA

RegPak BioPharma Consulting, The Netherlands

Sanofi Aventis, USA

Schering Plough Research Institute, USA

Schlich & Co, UK

Scott & White, USA

Sequoia Pharmaceuticals Inc., USA

SeraCare Life Sciences, USA

Shanghai Biochip Co., Ltd, China

Shenogen Pharma Group, China

Siena Biotech S.p.A. A company, USA

Simulations Plus, Inc., USA

Synta Pharmaceuticals Corp, USA

TEVA Pharmaceuticals, USA

The Takeda Oncology Company, USA

ThromboGenics, USA

Transgene, France

US Oncology Research, Inc., USA

Vaxinnate, USA

Wyeth Research, USA 


Zeptosens C a Division of Bayer (Schweiz) AG, Switzerland

Zhejiang Hisun Pharmaceutical Co., Ltd, China

Tehran University of Medical Sciences , Iran

CMBF 2009
(Aug. 8-10, 2009, Dalian, China)
RMSC 2009
(Aug. 8-10, 2009, Dalian, China)
IDDST 2009
(Oct.22-25, 2009, Shanghai, China)
CEMD 2009
(Nov.19-21, 2009, Beijing, China)
WCG 2009
(December 1-7, 2009, Foshan, China)
ICC 2009
(Dec. 5-7, 2009, Shanghai, China)
Pepcon 2010
(March 21-23, 2010, Beijing, China)
ICA 2010
(March 24-26, 2010, Beijing, China)
WCV 2010
(March 24-26, 2010, Beijing, China)
SEB 2010
(Apr. 22-24, 2010, Shanghai, China)
WCC-Breast Cancer 2010
Tri-Breast Cancer Conference

(Apr. 25-27, 2010, Shanghai, China)
WCIT 2010
(May 15-18, 2010, Beijing, China)
ICM 2010
(May 18-20, 2010, Beijing, China)
WCCAS 2010
(May 19-21, 2010, Beijing, China )
IBIO 2010
(July 25-27, 2010, Qingdao, China)
(July 31-August 3, 2010, Korea)

Past Conference Report

BIT's 7th International Drug Discovery Science and Technology (IDDST), held in Shanghai Everbright Convention and Exhibition Center on October 22-25, achieved a consummation. The theme of this conference is "Milestones of Innovative Therapeutics". Over 400 honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are Mr. Liu Hailin, Deputy Director-General of China Medicinal Biotech Association; Mr. Weimao Huang, Deputy Director of Shanghai Municipal Bureau of Foreign Experts; Dr. Xiaodan Mei, the Executive Chair of IDDST-2009, President of BIT Life Sciences; Dr. Aaron Ciechanover, Nobel Prize Laureate in Chemistry, 2004, Professor, Vascular and Cancer Biology Research Center, The Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Israel; Dr. Andreas Claudius Tschirky, the General Manager of Roche R&D Center China (RRDCC); Dr. Jing-Shan Hu, Director of Licensing & External Research (Mainland China, Hong Kong, & Taiwan), Merck & Co., USA; Dr. Chris Senanayake, Vice President, Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., USA; Derek Ren ( VP, Disocvery Biology,, Viva Biotech Ltd); Dr.Thierry Coche, Director Late Clinical Development Immunotherapeutics Business Unit, GlaxoSmithKline Biologicals S.A., Belgium; Dr.Christine Munz , Regional Marketing Manager, Asia Pacific. More than 600 world-renowned experts, professors, laboratory principals, project leaders and representatives of well-known enterprises attended the conference.

This annual congress comprised 8 Tracks and 61 sessions following the ceremony, including “Satellite Symposium: Emerging Approaches to Improve Medicine, sponsored by Roche Applied Science”; “Basic Sciences of Preclinical Studies”; “Methodology & Innovative tools for drug discovery, Drug delivery and Drug Development”; “Drug Discovery of Major Diseases”…etc. Meanwhile, A huge success has been achieved by BIT science in hosting IDDST annual congress in shanghai which also supported by OMICS, Roche, Merck & Co. Ltd. PerkinElmer Instruments, and Viva Biotech Ltd.

This annual conference, brought together nearly 600 specialists from 30 countries and areas, was devoted to the leading issues and popular topics and provide up-to-date information to all over the world. On the other hand, the meeting provided a brilliant information platform for domestic researchers to communicate with international experts and pushed forward the drug discovery development.

According to the investigation after the conference, most of our participants expressed that they would like to attend IDDST in the next year. Depending on the warmly support and good suggestions from all of the participants, we are quite confident in organizing IDDST-2010 which would be better and more successful than IDDST-2009. All of us are looking forward to meeting you again in 2010.

Aaron Ciechanover Andreas Claudius Tschirky Chris Senanayake
Christine Munz Derek Ren Hailin Liu
Jing-Shan Hu Thierry Coche Opening Ceremony
Opening Ceremony Opening Ceremony Opening Ceremony
Opening Ceremony Opening Ceremony Opening Ceremony
Opening Ceremony    

Click here for Conference brochure download
Click here for Conference brochure download
Click here for Conference brochure download

Chapter 1: Basic Sciences of Preclinical Studies
-Sciences is All We Need to Start
Chapter 5: Drug Discovery of Major Diseases
-Targeting Unsolved Life Threatening Diseases
Chapter 2:Smart Drug Discovery Chemistry
-Applied Robust Chemistry to Better Molecules
Chapter 6: New Heats for Biotherapeutics
-Discover Humanized Natural Bio-Drugs
Chapter 3: Methodologies & Innovative Tools for Drug Discovery, Drug Delivery and Drug Development
-Master the Matured Cutting-Edge Technologies for Drug Innovations
Chapter 7: Milestones of Novel Therapeutics Pipeline
-Update and Case Studies for Novel INDs on Trials
Chapter 4: Translational Medicine
-Bridge Pharm R & D from Bench to Bedside
Chapter 8: Outsourcing, Partnership, and Licensing across the World
- Cost Effective and Result Driving Forces

Prof. Aaron Ciechanover,
Nobel Prize Laureate in Chemistry, 2004;
Institute of Technology, Isreal

Dr. Vincent G. Brichard,
Vice President, Head of Immunotherapeutics Business Unit, GlaxoSmithKline Biologicals, Belgium

Dr. Chris Senanayake,
Vice President,
Chemical Development,
Ingelheim Pharmaceuticals,
Inc., USA

Dr. Andreas Tschirky,
Roche's head of R&D in China

Reserved for VP of Merck & Co, Inc, USA

Dr. Alex Kiselyov , President, deCODE chemistry, USA

Dr. Thaddeus Grasela,
President & CEO, Cognigen Corporation, USA

Dr. Miodrag Micic , Vice President, Research & Development, MP Biomedicals, LLC, USA

Dr. Michael F.G. Schmidt, Professor and Chairman, Dept. Immunology and Molecular Biology, Berlin Veterinary Faculty, Freie Universität Berlin, German y

Dr. M. Michael
Swindle, Professor &
Chairman Comparative Medicine, Medical University of South Carolina, USA

Dr. Karl-Anton Kreuzer, Professor, Department I of Internal Medicine, University at Cologne, Germany

Dr. King Lee, VP Regulatory/Clinical Affairs, Cornerstone Pharmaceuticals, USA

Dr. George Lin , Chief Medical Officer, Biological Mimetics, Inc., USA

Dr. Steven Bodovitz,
Principal, BioPerspectives,

Dr. Mirko Diksic , Professor & Director, McGill University, Canada

Dr. Dominic M. Desiderio, Professor, University of Tennessee Health Science Center, USA

Dr. Andrew K. Godwin , Director, Clinical Molecular Genetics Laboratory, Fox Chase Cancer
Center, USA

Dr. Peter Ghosh ,
CEO, ProteoBioactives Pty Ltd., Australia

Mr. Anthony Johnson, President/CEO,
Empire Genomics,

Dr. Tomi Sawyer , CSO, Aileron Therapeutics, USA

Dr. Sohaib Khan, Professor & Vice Chair, UC College of Medicine, USA

Dr. Johan Weigelt, Associate Director/Chief Scientist, Structural Genomics Consortium, Karolinska Institutet, Sweden

Dr. Matthias von Herrath,
Professor, University of California, San Francisco, USA

Dr. Jutta Bachmann, Principal and Founder, Bachmann Consulting, Norway

Dr. Dmitry Samarsky, Vice President, Technology Development, RXi Pharmaceuticals, USA

Dr. Ekambar Kandimalla, Vice President, Discovery, Idera Pharmaceuticals, USA

Dr. Leonard B. Saltz, Professor, Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, USA

Dr. Mark S. Kindy , Professor, Director of Neurosciences Institute, Medical University of South Carolina, USA

Dr. Mitchell Ho,
Head, Antibody Therapy Unit, National Cancer Institute, NIH, USA

Dr. John H. Van Drie, President, John H Van Drie Research LLC, USA

Dr. Manni Kantipudi , President, GVK Biosciences Private Limited, India

Dr. CSN Murthy, CEO, Aurigene Discovery Technologies Ltd, India

Dr. Edward O'Brien, Professor & Research Chair, University of Ottawa Heart Institute, Canada

Dr. Ronald J Quinn, Professor & Director, Eskitis Institute for Cell and Molecular Therapies, Griffith University, Australia

Dr. Hans-Joachim Knolker, Professor, Department at the Technical University of Dresden ,Germany

Dr. Nikolay Savchuk, CEO, Chemdiv, Russia

Dr. Goutam Das, COO, Syngene Intl Ltd, India

Dr. Swapan Bhattacharya, Managing Director, TCG Lifesciences, India

Dr. David Craik ,
Professor, Institute for Molecular Bioscience, The University of Queensland, Australia

Dr. Michael E. Johnson , Professor and Director, Center for Pharmaceutical Biotechnology, University of Illinois at Chicago, USA

Dr. Ingo Ott, Professor, Institute of Pharmaceutical Chemistry, Technical University Braunschweig, Germany

Dr. Lihu Yang , Director, Merck Research Laboratories, Merck & Co., USA

Dr. Jurgen Wagner, Director, Transplantation Research, Novartis Pharma AG, Switzerland

Dr. Ming Wang , Scientific Director, Amgen, Inc., USA

Dr. Eckard Hamelmann , Professor of Pediatrics and Allergy,Ruhr University, Germany

Dr. Oscar Joseph Trask, Head, Cellular Imaging Technologies, Duke University, USA

Dr. Tim Hammonds ,
Head , Biochemistry and HTS, Cancer Research Technology, UK

Dr. Jun Shi , Senior Director, Daiichi Sankyo Pharma Development, Japan

Dr. Steven Hayes,
Director, BellBrook Labs, LLC, USA

Dr. Josy Breuer , Senior Director, Bayer Schering Pharma AG, Germany

Dr. Paul M. Vanhoutte , Head, Department of Pharmacology and Pharmacy, Hong Kong, China

Dr. Wenlin Huang , Senior Research Fellow, Institute of Microbiology,Chinese Academy of Sciences., China

Dr. Robert Chunhua Zhao, Professor & Director, Chinese Academy of Medical Sciences and Peking Union Medical College,China

Dr. Duu-Gong Wu, Executive Director, ConsultingDivision, PharmaNet, Inc., USA

Dr. Berthold Hocher, Senior Clinical Research Director, Solvay Pharmaceuticals,Germany

Dr. Zhiyang Zhao , Director of Preclinical, Amgen Inc., USA

Dr. Frank Fan, Senior Research Manager, Promega Corporation, USA

Dr. Julie Jia, Account Manager, Millipore Corporation, USA

Dr. Andrew C. Chang, Executive Director,Pharmanet Development Group, Inc., USA

Dr. Shuhui Chen, CSO Wuxi Pharmatech, Shanghai, China

Dr. John Oyler, President & CEO , BioDuro (Beijing) Company Limited, China

Dr. Xiaochuan Wang , Chairman & CEO , Sundia MediTechCompany, Ltd,China

Dr. Anthony Piscopio, CEO,

Dr. Weiguo Su ,
Sr. VP, Drug Discovery, Hutchison MediPharma, China

Dr. Yajun Xu , Sr. VP, Business Development, ChemPartner, China

Dr. Boliang Lou, CEO, Pharmaron, China

Dr. Frank Zhang , CEO, GenScript Corporation, USA

Dr. Jintao Zhang, CEO, Medicilon/MPI Preclinical Research(Shanghai) LLC., China

Faming Zhang

Dr. Faming Zhang, President of CrownBio, China

Dr. Chunlin Chen, CEO, Shanghai Medicilon Inc., China

Dr. Jin Li, President, Shenogen Pharma Group, China

Dr. Ming-Qiang Zhang, Chief Technology Officer & Vice President of External Research, Roche R&D Centre Ltd, China

Dr. Jingwu Zang, Senior Vice President, GlaxoSmithKline (GSK) China R&D Center, China

Dr. Jason (Gang) Jin , CEO, ShanghaiBio Corporation (SBC for Global R&D Services in USA), China

Dr.Tina Huang, Vice President , Bridge pharmaceuticals, China

Dr. Jean-Pierre Wery, Executive Vice President, Crown BioScience, Inc., China

Dr. Zhenping Wu , Vice President, Hutchison MediPharma Limited, China

Dr. Jing-Shan Hu , Director of Merck In-Licensing, China

Dr. Stella Xu ,
Executive Director, Roche Pharma Partnering, China

Dr. Hequn Yin, Head, Shanghai R&D Center, Novartis, China

More ...

In 2009, this is an exciting time for those in drug discovery and development field once again. With the emphasis on the practical, actionable ideas for accelerating discovery and early development, the 7th congress will be the great opportunity for the world’s leading scientists and executives to share with you the latest advancements in viral studies and their strategic approaches to win the race to bring in the next blockbuster drug to market and milestones of innovative therapeutics. It encourages the mutual understanding between basic research and commercial purposes. It will be a unique conference place for updating both knowledge and translating cutting-edge scientific outcome and technology into industrial productivity for a new healthier world. Through IDDST congress 2009, you will gain a full coverage on the up-to-date with the booming drug R&D industry and its partnering potential in Asia, also deeply understand the market and current situation to get what you need, such as the strategies of major pharma players in integrating scientific, technological, talent and business resources in a flat world to increase business competitive capacities.

The congress of IDDST, initiated by BIT Life Sciences in 2003, has offered a unique across cultural meeting place of drug discovery in China. In the past six years, the congresses of IDDST have attracted more than world renowned speakers with over 40,000 professionals around the world as a leading international event for the professionals to sharing scientific information and seeking business opportunities in drug discovery fields through the annual congress and our tech tour programs in different cities of China. Many world prominent scientists, senior executives, entrepreneurs, and investors have joined us enthusiastically with diversified contributions to each congress of IDDST. You may find the Collection of previous conferences as following.

IDDST2008   IDDST2007   IDDST2006   IDDST2005   IDDST2004

Click to see larger view IDDST Congress 2009 is your best chance to showcase to drug discovery professionals in China. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee break, and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits. The IDDST 2009 will take place at Shanghai Everbright Convention and Exhibition Center. Lectures will be held on the 2nd floor of the build, immediately close to the exhibition area.

Why should you sponsor this event?
IDDST Congress 2009 is where your clients will come to look for solutions you can provide.
The event will offer a variety of conference and networking formats including; workshops, plenary sessions, parallel sessions, speed networking and a sociable drinks reception.

As a sponsor of this event you will be able to consider the most appropriate way to present your products and services and select a sponsorship package that is best suited to your marketing objectives and your preferred communication style. This event will deliver an excellent marketing and networking opportunity. By sponsoring or exhibiting at this event you will:

  • Learn from top level speakers
  • Uncover new opportunities and generate leads
  • Gain access to your target market
  • Integrate with the outsourcing and operations community
  • Enhance your brand and market position
  • Showcase your products and services
full screen on double click
Video: 1 2 3 4 5

Thank Merck for the generous sponsorship to IDDST-2009

Thank Roche for the generous sponsorship to the Welcome Banquet of IDDST-2009

Six Main Fields of Chinese pharmaceutical drug outsourcing companies, take part in this conference

Six Main Fields of indian pharmaceutical drug outsourcing companies, take part in this conference

The registration deadline for speakers is extended to Sep. 25. Register before that to enjoy the preference!

Reserve an exhibition stand at the IDDST 2009 exhibition book early to ensure optimum stand placement!

Merck & Co., Inc.

Roche R&D Center (China) Ltd.
Roche Applied Science

PerkinElmer Instruments
( Shanghai ) Co. Ltd

Viva Biotech Ltd

Viva Biotech Ltd.

BGI Shenzhen

Tri-I biotech(Shanghai)LTD.
Cambridge Crystallographic Data Centre
Shanghai Wellson Biotech Co., Ltd.
AstaTech(Chengdu)Pharmaceutical Co., Ltd.
Genscript Corporation
Colorcor China

IDEX Health & Science

Founder Software(Suzhou)
Co., Ltd.
Quantum Design Scientific Instrumentation Trading (Beijing) Co., Ltd.

Simulations Plus, Inc.

Gene Company Limited
Promega (Beijing) Biotech Co., Ltd.

SAGE Publications, Inc.


MicroConstants China Co., Ltd.

DL Instrument, Inc.

Araclon Biotech, S.L.., Spain


GL Biochem( Shanghai) Ltd


Roche Applied Science

Click to see larger view